Sign In

CPG Infobase: Clinical Practice Guidelines

0 comment(s)

Record Id:
14527
Title:
Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary
Fulltext:
View HTML (CMA members only. Login to cma.ca is required to access full-text.) (primary care)
Also available:
Français
Author
Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P
Publication/Review date:
2014-May 
Producers:
Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group
Society of Obstetricians and Gynaecologists of Canada

Bibliographic Source

Journal Citation:
J Obstet Gynaecol Can 2014;36(5):416–38.
Pages/Size:
23  Page(s)
References:
39
Notes:
SOGC clinical practice guideline No. 307

Subject Information

Specialties:
Cardiology, Obstetrics and gynecology,
Conditions:
Hypertension; Pregnancy;
Domains:
Preventive, Treatment, Diagnosis
Target Populations:
Pregnant or Nursing Mother
Target Gender:
Female
MeSH:
Hypertension, Pregnancy-Induced; Pre-Eclampsia; Pregnancy; Antihypertensive Agents; Perinatal Care;

Structured Abstract:

Objective:
This executive summary presents in brief the current evidence assessed in the clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy Working Group and published by Pregnancy Hypertension (http://www.pregnancyhypertension.org/article/S2210-7789(14)00004-X/fulltext) to provide a reasonable approach to the diagnosis, evaluation, and treatment of the hypertensive disorders of pregnancy.
Evidence
Published literature was retrieved through searches of Medline, CINAHL, and The Cochrane Library in March 2012 using appropriate controlled vocabulary (e.g., pregnancy, hypertension, pre-eclampsia, pregnancy toxemias) and key words (e.g., diagnosis, evaluation, classification, prediction, prevention, prognosis, treatment, postpartum follow-up). Results were restricted to systematic reviews, randomized control trials, controlled clinical trials, and observational studies published in French or English between January 2006 and February 2012. Searches were updated on a regular basis and incorporated in the guideline to September 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies.
Values:
The quality of evidence in the guideline summarized here was rated using the criteria described in the Report of the Canadian Task Force on Preventative Health Care (Table 1).

Copyright:

The copyright of this guideline and its companion documents belongs to: Society of Obstetricians and Gynaecologists of Canada

Disclaimer:
All content is provided for information and education and not as a substitute for the advice of a physician. Joule assumes no responsibility or liability arising from any error or omission or from the use of any information contained herein.

Discuss this CPG

Share your ideas and expertise on this topic.

​​​